$DD

DuPont (DD) Raises 2026 Adjusted EPS Outlook to $7.47–$7.52

DuPont (DD) reported Q3 2026 results exceeding expectations and raised its full-year outlook, projecting organic growth of 4.5%, Operating EBITDA of $1.785B, and adjusted EPS of $7.47–$7.52. The company did not provide prior-period comparisons for these figures.

Original reporting
Published Nov 3, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
DuPont (DD) Raises 2026 Adjusted EPS Outlook to $7.47–$7.52 — source image
Decision brief

The 30-second read

$DDBullishHigh
01

Why it matters

The guidance lift is a primary catalyst that can move the stock immediately, offering a clear trading decision.

02

Market read

A large‑cap industrial stock with fresh positive guidance, likely to attract buying interest.

03

What to watch

Potential supply‑chain constraints or raw‑material cost pressures could temper the upside.

Relevance 8/10Novelty 8/10Timing: today

Background

DuPont's Q3 results beat its own guidance, prompting an upward revision of full‑year EPS and EBITDA forecasts.

Company-level read

Ticker impact

$DDBullishHigh confidence
Context

DuPont raised its 2026 adjusted EPS outlook to $7.47‑$7.52 and Q3 operating EBITDA to $1.785B, a fresh guidance update.

Expected impact

upward pressure as investors price in higher EPS expectations

Evidence & confidence

The new EPS range exceeds prior expectations, a material positive catalyst for a large‑cap stock.

Market effects

Chemicals sector may see a lift as DuPont signals stronger demand and pricing power.

U.S. market could see modest gains in industrials following the upbeat guidance.

Limited to investors tracking large‑cap industrials; no broad macro effect.

Counterpoint

If the guidance raise is already priced in, the stock could face a short‑term pullback.

Key entities

  • DuPont de Nemours, Inc.

    Global chemicals and materials company.

Related articles

$DDMed

DuPont de Nemours, Inc. Q3 2026 Earnings Call Summary

DuPont reported Q3 2026 organic growth of 5%, driven by healthcare, aerospace, and semiconductor demand. Margin expansion of 90 bps resulted from productivity gains. AI reduced R&D project time. Building Technologies gained market share. The company plans $250M in share repurchases. Full-year guidance was raised to 4.5% organic growth. Middle East disruptions and oil/gas inflation are risks. Management targets 3% COGS reduction and a 50/50 innovation mix.

$DDHighAI 8/10

DuPont Reports Third Quarter 2026 Results

DuPont de Nemours, Inc. (DD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 DuPont Reports Third Quarter 2026 Results Exceeds Third Quarter 2026 Guidance Raises Full Year 2026 Guidance Third Quarter 2026 Highlights • Net Sales of $1.9 billion increased 4%; organic sales increased 5% versus year-ago period • GAAP Income from continuing operat

$DDHighAI 8/10

DuPont Boosts FY26 Outlook As Q3 Swings To Profit

DuPont (DD) reported Q3 net income of $123M ($0.91 per share), swinging to profit from a year-ago loss. Q4 guidance: $1.90-$1.95 EPS on $1.825B sales. Raised FY26 outlook to $7.47-$7.52 EPS on $7.19B sales, up from prior $7.17-$7.32 EPS. Q3 sales grew 4% to $1.868B. Plans $250M share buyback. Pre-market: DD +0.50%.